Brighton Collaboration
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
 Service Mark of the Brighton Collaboration Foundation | |
| Formation | 2000 |
|---|---|
| Type | NPO |
| Purpose | Safest, effective vaccines based on rigorous science To enhance the science of vaccine research by providing standardized, validated, and objective methods for continuous monitoring of safety profiles and by assessing benefit-risk ratios. These methods are, in turn, recognized and recommended for use by international regulatory and public health agencies.[1] |
| Headquarters | Basel, Switzerland |
Region served | Worldwide |
Official language | English |
| Leader | Jan Bonhoeffer, president |
Parent organization | Task Force for Global Health |
| Affiliations | Coalition for Epidemic Preparedness Innovations |
| Website | brightoncollaboration.us |
The Brighton Collaboration (BC) is a non-profit global vaccine safety research network based in Basel, Switzerland. It is named after the city in England where the idea was first formulated.[2]
History
[edit]The Brighton Collaboration was launched in 2000, although the idea of the collaboration started one year earlier, following a presentation by Bob Chen at an international scientific vaccine conference in Brighton. In his talk, he stressed the need to improve vaccine safety monitoring by developing internationally accepted standards.[3]
Organization
[edit]The Brighton Collaboration is a program of the Task Force for Global Health, a 501(c)(3) non-profit organization. It is primarily funded by the Coalition for Epidemic Preparedness Innovations (CEPI), and has received funding from a variety of scientific and public health organizations since its inception.[4]
Non-funding partners of the Collaboration include the Council for International Organizations of Medical Sciences, European Medicines Agency, Food and Drug Administration and the World Health Organization.[4]
References
[edit]- ^ "EVI and Brighton Collaboration Foundation (BCF) sign Memorandum of Understanding (MoU)". Archived from the original on 2011-10-31. Retrieved 2012-07-17.
- ^ Kohl, Katrin S.; Bonhoeffer, Jan; Braun, M. Miles; Chen, Robert T.; Duclos, Philippe; Heijbel, Harald; Heininger, Ulrich; Loupi, Elisabeth; Marcy, S. Michael (February 2005), Henriksen, Kerm; Battles, James B.; Marks, Eric S.; Lewin, David I. (eds.), "The Brighton Collaboration: Creating a Global Standard for Case Definitions (and Guidelines) for Adverse Events Following Immunization", Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology), Advances in Patient Safety, Rockville (MD): Agency for Healthcare Research and Quality (US), PMID 21249832, archived from the original on 2022-12-12, retrieved 2023-07-04
- ^ Chen RT (1999). "Vaccine risks: real, perceived and unknown". Vaccine. 17 (Suppl 3): S41-6. doi:10.1016/s0264-410x(99)00292-3. PMID 10559533.
- ^ a b "Our Partners". Brighton Collaboration. Archived from the original on 2023-07-04. Retrieved 2023-07-04.
 | This Switzerland-related article is a stub. You can help Wikipedia by expanding it. |